Nonalcoholic fatty liver disease burden
Nicolas Goossens(University Hospital of Geneva), David Semela(Kantonsspital St. Gallen), François R. Jornayvaz(University of Geneva), Homie Razavi(Center for Disease Analysis), Stefano Bellentani(Ospedale Regionale di Locarno), Andreas Cerny(Epatocentro Ticino), Chris Estes(Center for Disease Analysis), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Jean‐François Dufour(Universidad Iberoamericana), Alberto Moriggia(University of Zurich), Beat Muellhaupt, Francesco Negro(University Hospital of Geneva)
Archive ouverte UNIGE (University of Geneva)
January 1, 2019
Cited by 2
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
|Hepatology|2017|2.4k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
Global epidemiology and genotype distribution of the hepatitis C virus infection
|Journal of Hepatology|2014|1.9k